pentaerythritol tetranitrate has been researched along with Preterm Birth in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodowski, L; Condic, M; de Vries, L; Delius, M; Eckmann-Scholz, C; Friebe-Hoffmann, U; Groten, T; Hoopmann, M; Hübener, C; Jäger, Y; Kagan, KO; Komar, M; Kraft, K; Lato, K; Lehmann, T; Pecks, U; Schlembach, D; Schleußner, E; Schrey-Petersen, S; Seeger, S; Seliger, G; Sroka, D; Städtler, M; Strizek, B; Tauscher, A; Verlohren, S; von Kaisenberg, CS; Winkler, JL | 1 |
| Groten, T; Kähler, C; Lehmann, T; Schlembach, D; Schleussner, E; Schneider, U | 1 |
2 trial(s) available for pentaerythritol tetranitrate and Preterm Birth
| Article | Year |
|---|---|
Effect of pentaerythritol tetranitrate (PETN) on the development of fetal growth restriction in pregnancies with impaired uteroplacental perfusion at midgestation-a randomized trial.
Topics: Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Pentaerythritol Tetranitrate; Perfusion; Perinatal Death; Placenta; Placentation; Pregnancy; Premature Birth | 2023 |
Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: a prospective, randomized, double-blinded trial.
Topics: Abruptio Placentae; Double-Blind Method; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Nitric Oxide Donors; Pentaerythritol Tetranitrate; Perinatal Death; Placenta; Placenta Diseases; Placentation; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Premature Birth; Prospective Studies; Ultrasonography, Prenatal; Uterine Artery; Vasodilator Agents | 2014 |